Variation in gene expression patterns in follicular lymphoma and the response to rituximab

被引:112
作者
Bohen, SP
Troyanskaya, OG
Alter, O
Warnke, R
Botstein, D [1 ]
Brown, PO
Levy, R
机构
[1] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA
关键词
D O I
10.1073/pnas.0437875100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Analysis of the patterns of gene expression in follicular lymphomas from 24 patients suggested that two groups of tumors might be distinguished. All patients, whose biopsies were obtained before any treatment, were treated with rituximab, a monoclonal antibody directed against the B cell antigen, CD20. Gene expression patterns in the tumors that subsequently failed to respond to rituximab appeared more similar to those of normal lymphoid tissues than to gene expression patterns of tumors from rituximab responders. These findings suggest the possibility that the response of follicular lymphoma to rituximab treatment may be predicted from the gene expression pattern of tumors.
引用
收藏
页码:1926 / 1930
页数:5
相关论文
共 18 条
[1]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]   Singular value decomposition for genome-wide expression data processing and modeling [J].
Alter, O ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10101-10106
[3]   Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].
Cartron, G ;
Dacheux, L ;
Salles, G ;
Solal-Celigny, P ;
Bardos, P ;
Colombat, P ;
Watier, H .
BLOOD, 2002, 99 (03) :754-758
[4]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[5]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[6]   Diversity of gene expression in adenocarcinoma of the lung [J].
Garber, ME ;
Troyanskaya, OG ;
Schluens, K ;
Petersen, S ;
Thaesler, Z ;
Pacyna-Gengelbach, M ;
van de Rijn, M ;
Rosen, GD ;
Perou, CM ;
Whyte, RI ;
Altman, RB ;
Brown, PO ;
Botstein, D ;
Petersen, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13784-13789
[7]  
GHIA P, 2002, SEMIN CANC BIOL
[8]  
Golay J, 2000, BLOOD, V95, P3900
[9]   Clustered CD20 induced apoptosis: Src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis [J].
Hofmeister, JK ;
Cooney, D ;
Coggeshall, KM .
BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (02) :133-143
[10]   Rituximab: Mechanism of action and resistance [J].
Maloney, DG ;
Smith, B ;
Rose, A .
SEMINARS IN ONCOLOGY, 2002, 29 (01) :2-9